Approximately two-thirds of the world's population under the age of 50 years have oral or genital herpes simplex type 1 (HSV-1) infection, while one in eight have herpes simplex type 2 (HSV-2) ...

Aicuris’s pritelivir is forecast to be a significant advancement for immunocompromised patients with refractory HSV ...

Background. Herpes simplex virus type 2 (HSV-2) reactivations are associated with increased HIV load, but whether HSV-2 coinfection accelerates HIV disease is unclear. We compared rates of CD4 count ...

Innovative Molecules' adibelivir had a favourable pharmacokinetic profile and proved safe and efficacious in Phase I clinical ...

Vaccines are one of the most important medical inventions of modern times that have saved and enhanced innumerable lives around the world. Despite the technological advances in vaccine design and ...

Herpes simplex virus type 1 (HSV-1) most commonly causes cold sores while HSV-2 is associated with genital herpes. But, it’s also possible to contract an HSV-2 infection in the mouth from sex without ...

HealthDay News — A once-promising investigational vaccine against herpes viruses showed only 20% efficacy against herpes genital disease in a large clinical trial designed to mimic the general ...

Herpes simplex virus is a common infection that typically appears in and around the mouth (oral herpes) or the genitals (genital herpes). Ulcers may cause pain but usually resolve within a few days or ...

Genital herpes is a common and incurable sexually transmitted disease (STD). It’s so prevalent in the United States that about 1 in 6 people ages 14 to 49 have it. More American women than men have ...